ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
GSK's anti-seizure drug shows promise in early depression study
November 20, 2018Researchers have found that GlaxoSmithKline’s ezogabine (Potiga), approved by the FDA in 2011 as an anti-seizure therapy, could have applications as a treatmen -
Researchers have found that GlaxoSmithKline’s ezogabine (Potiga), approved by the FDA in 2011 as an anti-seizure therapy, could have applications as a treatment for treatment-resistant depression
November 06, 2018Following its approval in the US, the FDA ordered GSK to conduct additional safety studies after concerns were raised that the drug’s use could affect... -
GSK's anti-seizure drug shows promise in early depression study
November 05, 2018Researchers have found that GlaxoSmithKline’s ezogabine (Potiga), approved by the FDA in 2011 as an anti-seizure therapy, could have ....
Pharma Sources Insight January 2025
